More about

Retina

News
July 09, 2024
1 min read
Save

Prior authorizations for anti-VEGFs cause treatment delays, administrative burdens

The current prior authorization process required for anti-VEGF medications leads to treatment delays, increased health care costs due to administrative burdens and potentially worse visual outcomes.

News
July 09, 2024
1 min read
Save

Genentech to reintroduce Susvimo for wet AMD

Genentech is set to reintroduce Susvimo for patients with wet age-related macular degeneration nearly 2 years after it voluntarily recalled the ocular implant, according to a press release.

News
July 05, 2024
2 min watch
Save

VIDEO: Kriya reviews geographic atrophy, thyroid eye disease gene therapies

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Shankar Ramaswamy, MD, of Kriya Therapeutics highlights the company’s gene therapy programs for geographic atrophy and thyroid eye disease.

News
July 03, 2024
3 min watch
Save

VIDEO: AVD-104 for geographic atrophy well tolerated at 3 months

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Arshad M. Khanani, MD, MA, FASRS, of Sierra Eye Associates in Nevada, presents 3-month data on AVD-104 for geographic atrophy.

News
July 02, 2024
1 min read
Save

Alcon acquires Belkin Vision, direct selective laser trabeculoplasty device

Alcon completed the acquisition of Belkin Vision, including its direct selective laser trabeculoplasty technology, according to a press release.

News
June 29, 2024
4 min watch
Save

VIDEO: Yutiq shows positive real-world results in chronic noninfectious uveitis at 3 years

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Michael Singer, MD, of the University of Texas Health Science Center, discusses 36-month data investigating Yutiq for chronic noninfectious uveitis.

News
June 28, 2024
1 min read
Save

Apellis seeks reexamination after negative opinion for pegcetacoplan in Europe

The Committee for Medicinal Products for Human Use of the European Medicines Agency issued a negative opinion on the marketing authorization application for pegcetacoplan for the treatment of geographic atrophy.

News
June 27, 2024
3 min watch
Save

VIDEO: Outlook Therapeutics enrolling patients in trial of ONS-5010

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Russ Trenary, president and CEO of Outlook Therapeutics, discusses the development of ONS-5010.

News
June 25, 2024
1 min read
Save

FDA clears Alcon’s Unity cataract system, Unity vitreoretinal cataract system

The FDA granted 510(k) clearance to Alcon’s Unity combined vitreoretinal cataract system and stand-alone cataract system, according to a press release.

News
June 23, 2024
1 min watch
Save

VIDEO: Annexon previews emerging data on ANX007 for geographic atrophy

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Lori Taylor of Annexon Biosciences previews data on ANX007 for the treatment of geographic atrophy.

View more